世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

バイオシミラーの世界市場規模調査、製品別（モノクローナル抗体、インスリン、顆粒球コロニー刺激因子、エリスロポエチン、遺伝子組み換えヒト成長ホルモン、エタネルセプト、フォリトロピン、テリパラチド、インターフェロン、エノキサパリンナトリウム、グルカゴン、カルシトニン）。エノキサパリンナトリウム、グルカゴン、カルシトニン）、適応症別（がん、炎症・自己免疫疾患、慢性疾患、血液疾患、成長ホルモン欠乏症、感染症、その他の適応症）、地域別予測 2022-2028


Global Biosimilars Market Size study, By Product (Monoclonal Antibodies, Insulin, Granulocyte Colony-Stimulating Factor, Erythropoietin, Recombinant Human Growth Hormone, Etanercept, Follitropin, Teriparatide, Interferons, Enoxaparin Sodium, Glucagon, Calcitonin), By Indication (Oncology, Inflammatory & Autoimmune Disorders, Chronic Diseases, Blood Disorders, Growth Hormone Deficiency, Infectious Diseases, Other Indications), and Regional Forecasts 2022-2028

世界のバイオシミラー市場は、2021年に約156億米ドルと評価され、予測期間2022-2028年には23.5%を超える健全な成長率で成長すると予想されています。バイオシミラーとは、生物学的医療品目のことで、元の品目の均... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 言語
Bizwit Research & Consulting LLP
ビズウィットリサーチ&コンサルティング 		2022年4月22日 US$4,950
シングルユーザーライセンス
ライセンス・価格情報
注文方法はこちら 		200 英語

　

サマリー

世界のバイオシミラー市場は、2021年に約156億米ドルと評価され、予測期間2022-2028年には23.5%を超える健全な成長率で成長すると予想されています。バイオシミラーとは、生物学的医療品目のことで、元の品目の均質なコピーであり、さらなる組織によって生産されるものである。バイオシミラーは、オリジナルのイノベーター製品の合法的に許可された品種であり、オリジナル製品の特許が切れたときに生産することが可能です。高齢者人口の増加や慢性疾患の増加、費用対効果の高さによるバイオシミラー医薬品の需要の高まり、規制当局の承認プロセスの短縮、互換性の概念が、世界的な市場需要の主な推進要因となっています。例えば、Biocon BiologicsはViatris, Inc.と提携し、2021年7月に糖尿病の治療に使用される世界初の互換性のあるバイオシミラー医薬品SEMGLEE（インスリン グラルギン-yfgn注射剤）のFDAの承認を取得しました。しかし、製造における複雑さが2022-2028年の予測期間における市場の成長を阻害しています。また、新しい適応症の導入のための研究投資の増加が、予測期間中の市場需要の触媒として作用すると予想されます。

バイオシミラーの世界市場調査において考慮した主要地域は、アジア太平洋地域、北米、ヨーロッパ、中南米、その他の地域です。欧州は、慢性疾患の発生率の増加や新しいバイオシミラーの導入により、市場シェアの面で世界の主要地域となっています。一方、アジア太平洋地域は、2022年から2028年の予測期間において、最も高いCAGRを示すと予想されています。人口の増加、新規プレイヤーの出現、市場への早期参入などの要因は、アジア太平洋地域全体のバイオシミラー市場に有利な成長見通しを生み出すでしょう。

本レポートに含まれる主な市場プレイヤーは以下の通りです。
サムスンバイオロジクス
インタス・ファーマシューティカルズ・リミテッド
セルトリオン
リライアンス・ライフサイエンス
ファイザー株式会社
コーヘラス・バイオサイエンス
ドクター・レディーズ・ラボラトリーズLtd.
アムジェン
バイオコン・リミテッド
アポテックス・インク

本調査の目的は、近年における様々なセグメント＆国の市場規模を定義し、今後8年間の値を予測することです。本レポートは、調査対象となる各地域および各国における産業の質的および量的な側面を取り込むように設計されています。さらに、市場の将来的な成長を規定する駆動因子や課題などの重要な側面に関する詳細な情報も提供しています。さらに、本レポートでは、主要企業の競争環境と製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場で利用可能な機会も組み込まなければなりません。市場の詳細なセグメントとサブセグメントを以下に説明します。
製品別
モノクローナル抗体
インスリン
顆粒球コロニー刺激因子（GSCF)
エリスロポエチン
遺伝子組換えヒト成長ホルモン
エタネルセプト
フォリトロピン
テリパラチド
インターフェロン
エノキサパリンナトリウム
グルカゴン
カルシトニン
適応症別
がん領域
炎症性疾患および自己免疫疾患
慢性疾患
血液疾患
成長ホルモン欠乏症
感染症
その他の適応症
地域別
北米
米国
カナダ
欧州
英国
ドイツ
フランス
スペイン
イタリア
ROE

アジア太平洋地域
中国
インド
日本
オーストラリア
韓国
ロアパック
ラテンアメリカ
ブラジル
メキシコ
その他の地域

さらに、調査のために考慮した年は以下の通りです。

過去年 - 2018年,2019年,2020年
基準年 - 2021年
予測期間 - 2022年～2028年

市場調査における世界のバイオシミラー市場のターゲットオーディエンス。

主要なコンサルティング会社およびアドバイザー
大企業、中堅企業、中小企業
ベンチャーキャピタル
付加価値再販業者(VAR)
サードパーティー・ナレッジ・プロバイダー
投資銀行家
投資家







ページTOPに戻る


目次

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028(USD Billion)
1.2.1. Biosimilars Market, by Region, 2020-2028(USD Billion)
1.2.2. Biosimilars Market, by Product, 2020-2028(USD Billion)
1.2.3. Biosimilars Market, by Indication, 2020-2028(USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Biosimilars Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Biosimilars Market Dynamics
3.1. Biosimilars Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Increasing geriatric population and the growing incidence of chronic diseases
3.1.1.2. Increasing demand for biosimilar drugs
3.1.2. Market Challenges
3.1.2.1. Complexities in manufacturing
3.1.3. Market Opportunities
3.1.3.1. Increasing investment for the introduction of new indications
Chapter 4. Global Biosimilars Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2019-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Biosimilars Market, by Product
6.1. Market Snapshot
6.2. Global Biosimilars Market by Product, Performance - Potential Analysis
6.3. Global Biosimilars Market Estimates & Forecasts by Product, 2019-2028 (USD Billion)
6.4. Biosimilars Market, Sub Segment Analysis
6.4.1. Monoclonal Antibodies
6.4.2. Insulin
6.4.3. Granulocyte Colony-Stimulating Factor
6.4.4. Erythropoietin
6.4.5. Recombinant Human Growth Hormone
6.4.6. Etanercept
6.4.7. Follitropin
6.4.8. Teriparatide
6.4.9. Interferons
6.4.10. Enoxaparin Sodium
6.4.11. Glucagon
6.4.12. Calcitonin
Chapter 7. Global Biosimilars Market, by Indication
7.1. Market Snapshot
7.2. Global Biosimilars Market by Indication, Performance – Potential Analysis
7.3. Global Biosimilars Market Estimates & Forecasts by Indication, 2019-2028 (USD Billion)
7.4. Biosimilars Market, Sub Segment Analysis
7.4.1. Oncology
7.4.2. Inflammatory & Autoimmune Disorders
7.4.3. Chronic Diseases
7.4.4. Blood Disorders
7.4.5. Growth Hormone Deficiency
7.4.6. Infectious Diseases
7.4.7. Other Indications
Chapter 8. Global Biosimilars Market, Regional Analysis
8.1. Biosimilars Market, Regional Market Snapshot
8.2. North America Biosimilars Market
8.2.1. U.S. Biosimilars Market
8.2.1.1. Product breakdown estimates & forecasts, 2019-2028
8.2.1.2. Indication breakdown estimates & forecasts, 2019-2028
8.2.2. Canada Biosimilars Market
8.3. Europe Biosimilars Market Snapshot
8.3.1. U.K. Biosimilars Market
8.3.2. Germany Biosimilars Market
8.3.3. France Biosimilars Market
8.3.4. Spain Biosimilars Market
8.3.5. Italy Biosimilars Market
8.3.6. Rest of Europe Biosimilars Market
8.4. Asia-Pacific Biosimilars Market Snapshot
8.4.1. China Biosimilars Market
8.4.2. India Biosimilars Market
8.4.3. Japan Biosimilars Market
8.4.4. Australia Biosimilars Market
8.4.5. South Korea Biosimilars Market
8.4.6. Rest of Asia Pacific Biosimilars Market
8.5. Latin America Biosimilars Market Snapshot
8.5.1. Brazil Biosimilars Market
8.5.2. Mexico Biosimilars Market
8.6. Rest of The World Biosimilars Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Samsung Biologics
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Intas Pharmaceuticals Ltd.
9.2.3. Celltrion
9.2.4. Reliance Life Sciences
9.2.5. Pfizer, Inc.
9.2.6. Coherus BioSciences
9.2.7. Dr. Reddy’s Laboratories Ltd.
9.2.8. Amgen, Inc.
9.2.9. Biocon Limited
9.2.10. Apotex, Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption


List of Tables
TABLE 1. Global Biosimilars market, report scope
TABLE 2. Global Biosimilars market estimates & forecasts by Region 2019-2028 (USD Billion)
TABLE 3. Global Biosimilars market estimates & forecasts by Product 2019-2028 (USD Billion)
TABLE 4. Global Biosimilars market estimates & forecasts by Indication 2019-2028 (USD Billion)
TABLE 5. Global Biosimilars market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 6. Global Biosimilars market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 7. Global Biosimilars market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 8. Global Biosimilars market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 9. Global Biosimilars market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 10. Global Biosimilars market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 11. Global Biosimilars market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 12. Global Biosimilars market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 13. Global Biosimilars market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 14. Global Biosimilars market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 15. U.S. Biosimilars market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 16. U.S. Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 17. U.S. Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 18. Canada Biosimilars market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 19. Canada Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 20. Canada Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 21. UK Biosimilars market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 22. UK Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 23. UK Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 24. Germany Biosimilars market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 25. Germany Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 26. Germany Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 27. RoE Biosimilars market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 28. RoE Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 29. RoE Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 30. China Biosimilars market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 31. China Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 32. China Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 33. India Biosimilars market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 34. India Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 35. India Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 36. Japan Biosimilars market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 37. Japan Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 38. Japan Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 39. RoAPAC Biosimilars market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 40. RoAPAC Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 41. RoAPAC Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 42. Brazil Biosimilars market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 43. Brazil Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 44. Brazil Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 45. Mexico Biosimilars market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 46. Mexico Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 47. Mexico Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 48. RoLA Biosimilars market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 49. RoLA Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 50. RoLA Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 51. Row Biosimilars market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 52. Row Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 53. Row Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 54. List of secondary sources, used in the study of global Biosimilars market
TABLE 55. List of primary sources, used in the study of global Biosimilars market
TABLE 56. Years considered for the study
TABLE 57. Exchange rates considered

　

ページTOPに戻る


　

Summary

Global Biosimilars Market is valued at approximately USD 15.60 Billion in 2021 and is anticipated to grow with a healthy growth rate of more than 23.5% over the forecast period 2022-2028. A biosimilar is a biologic medical item that is a homogenous copy of an original item, which is produced by a further organization. Biosimilars are legitimately permitted varieties of original innovator products and can be produced when the original product's patent expires. The increasing geriatric population and the growing prevalence of chronic diseases, escalating demand for biosimilar drugs owing to its cost-effectiveness, as well as abbreviated regulatory approval process and concept of interchangeability are the chief driving factors for the market demand across the globe. For instance, Biocon Biologics in partnership with Viatris, Inc. received the approval of the FDA In July 2021 for the world’s first interchangeable biosimilar SEMGLEE (insulin glargine-yfgn injection) that is used for the treatment of diabetes. However, complexities in manufacturing impede the growth of the market over the forecast period of 2022-2028. Also, increasing investment in the research for the introduction of new indications is anticipated to act as a catalyzing factor for the market demand during the forecast period.

The key regions considered for the global Biosimilars market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. Europe is the leading region across the world in terms of market share owing to the growing incidence of chronic disorders and the introduction of new biosimilars. Whereas, Asia-Pacific is also anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the increasing population, as well as the emergence of new players and early entry into the market, would create lucrative growth prospects for the Biosimilars market across the Asia-Pacific region.

Major market players included in this report are:
Samsung Biologics
Intas Pharmaceuticals Ltd.
Celltrion
Reliance Life Sciences
Pfizer, Inc.
Coherus BioSciences
Dr. Reddy’s Laboratories Ltd.
Amgen, Inc.
Biocon Limited
Apotex, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product
Monoclonal Antibodies
Insulin
Granulocyte Colony-Stimulating Factor
Erythropoietin
Recombinant Human Growth Hormone
Etanercept
Follitropin
Teriparatide
Interferons
Enoxaparin Sodium
Glucagon
Calcitonin
By Indication
Oncology
Inflammatory & Autoimmune Disorders
Chronic Diseases
Blood Disorders
Growth Hormone Deficiency
Infectious Diseases
Other Indications
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019,2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Biosimilars Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors







ページTOPに戻る


Table of Contents

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028(USD Billion)
1.2.1. Biosimilars Market, by Region, 2020-2028(USD Billion)
1.2.2. Biosimilars Market, by Product, 2020-2028(USD Billion)
1.2.3. Biosimilars Market, by Indication, 2020-2028(USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Biosimilars Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Biosimilars Market Dynamics
3.1. Biosimilars Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Increasing geriatric population and the growing incidence of chronic diseases
3.1.1.2. Increasing demand for biosimilar drugs
3.1.2. Market Challenges
3.1.2.1. Complexities in manufacturing
3.1.3. Market Opportunities
3.1.3.1. Increasing investment for the introduction of new indications
Chapter 4. Global Biosimilars Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2019-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Biosimilars Market, by Product
6.1. Market Snapshot
6.2. Global Biosimilars Market by Product, Performance - Potential Analysis
6.3. Global Biosimilars Market Estimates & Forecasts by Product, 2019-2028 (USD Billion)
6.4. Biosimilars Market, Sub Segment Analysis
6.4.1. Monoclonal Antibodies
6.4.2. Insulin
6.4.3. Granulocyte Colony-Stimulating Factor
6.4.4. Erythropoietin
6.4.5. Recombinant Human Growth Hormone
6.4.6. Etanercept
6.4.7. Follitropin
6.4.8. Teriparatide
6.4.9. Interferons
6.4.10. Enoxaparin Sodium
6.4.11. Glucagon
6.4.12. Calcitonin
Chapter 7. Global Biosimilars Market, by Indication
7.1. Market Snapshot
7.2. Global Biosimilars Market by Indication, Performance – Potential Analysis
7.3. Global Biosimilars Market Estimates & Forecasts by Indication, 2019-2028 (USD Billion)
7.4. Biosimilars Market, Sub Segment Analysis
7.4.1. Oncology
7.4.2. Inflammatory & Autoimmune Disorders
7.4.3. Chronic Diseases
7.4.4. Blood Disorders
7.4.5. Growth Hormone Deficiency
7.4.6. Infectious Diseases
7.4.7. Other Indications
Chapter 8. Global Biosimilars Market, Regional Analysis
8.1. Biosimilars Market, Regional Market Snapshot
8.2. North America Biosimilars Market
8.2.1. U.S. Biosimilars Market
8.2.1.1. Product breakdown estimates & forecasts, 2019-2028
8.2.1.2. Indication breakdown estimates & forecasts, 2019-2028
8.2.2. Canada Biosimilars Market
8.3. Europe Biosimilars Market Snapshot
8.3.1. U.K. Biosimilars Market
8.3.2. Germany Biosimilars Market
8.3.3. France Biosimilars Market
8.3.4. Spain Biosimilars Market
8.3.5. Italy Biosimilars Market
8.3.6. Rest of Europe Biosimilars Market
8.4. Asia-Pacific Biosimilars Market Snapshot
8.4.1. China Biosimilars Market
8.4.2. India Biosimilars Market
8.4.3. Japan Biosimilars Market
8.4.4. Australia Biosimilars Market
8.4.5. South Korea Biosimilars Market
8.4.6. Rest of Asia Pacific Biosimilars Market
8.5. Latin America Biosimilars Market Snapshot
8.5.1. Brazil Biosimilars Market
8.5.2. Mexico Biosimilars Market
8.6. Rest of The World Biosimilars Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Samsung Biologics
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Intas Pharmaceuticals Ltd.
9.2.3. Celltrion
9.2.4. Reliance Life Sciences
9.2.5. Pfizer, Inc.
9.2.6. Coherus BioSciences
9.2.7. Dr. Reddy’s Laboratories Ltd.
9.2.8. Amgen, Inc.
9.2.9. Biocon Limited
9.2.10. Apotex, Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption


List of Tables
TABLE 1. Global Biosimilars market, report scope
TABLE 2. Global Biosimilars market estimates & forecasts by Region 2019-2028 (USD Billion)
TABLE 3. Global Biosimilars market estimates & forecasts by Product 2019-2028 (USD Billion)
TABLE 4. Global Biosimilars market estimates & forecasts by Indication 2019-2028 (USD Billion)
TABLE 5. Global Biosimilars market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 6. Global Biosimilars market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 7. Global Biosimilars market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 8. Global Biosimilars market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 9. Global Biosimilars market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 10. Global Biosimilars market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 11. Global Biosimilars market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 12. Global Biosimilars market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 13. Global Biosimilars market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 14. Global Biosimilars market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 15. U.S. Biosimilars market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 16. U.S. Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 17. U.S. Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 18. Canada Biosimilars market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 19. Canada Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 20. Canada Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 21. UK Biosimilars market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 22. UK Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 23. UK Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 24. Germany Biosimilars market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 25. Germany Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 26. Germany Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 27. RoE Biosimilars market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 28. RoE Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 29. RoE Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 30. China Biosimilars market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 31. China Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 32. China Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 33. India Biosimilars market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 34. India Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 35. India Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 36. Japan Biosimilars market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 37. Japan Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 38. Japan Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 39. RoAPAC Biosimilars market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 40. RoAPAC Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 41. RoAPAC Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 42. Brazil Biosimilars market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 43. Brazil Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 44. Brazil Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 45. Mexico Biosimilars market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 46. Mexico Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 47. Mexico Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 48. RoLA Biosimilars market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 49. RoLA Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 50. RoLA Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 51. Row Biosimilars market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 52. Row Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 53. Row Biosimilars market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 54. List of secondary sources, used in the study of global Biosimilars market
TABLE 55. List of primary sources, used in the study of global Biosimilars market
TABLE 56. Years considered for the study
TABLE 57. Exchange rates considered

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（薬学的薬物）の最新刊レポート

Bizwit Research & Consulting LLP社のその他分野での最新刊レポート

本レポートと同じKEY WORD（biosimilars）の最新刊レポート


よくあるご質問


Bizwit Research & Consulting LLP社はどのような調査会社ですか?


Bizwit Research & Consulting (Bizwit Research & Consulting LLP)は世界の多様なマクロおよびマイクロ経済の動向を継続的に調査しています。 ... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/11/14　10:27

156.77 円

166.04 円

201.95 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.